Selected research
Market Structure
Global Enalapril Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Enalapril market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Enalapril is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Enalapril is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Enalapril is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Enalapril is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Enalapril include Wockhardt Americas Inc, Watson Laboratories Inc, Teva Pharmaceuticals Usa Inc, Teva Parenteral Medicines Inc, Taro Pharmaceutical Industries Ltd, Sandoz Inc, Ranbaxy Laboratories Ltd, Mylan Pharmaceuticals Inc and Lek Pharmaceuticals D D, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Enalapril market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Enalapril and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Enalapril sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Enalapril market size, projected growth trends, production technologies, key applications, and end-use industries.
Enalapril Segment by Company
Wockhardt Americas Inc
Watson Laboratories Inc
Teva Pharmaceuticals Usa Inc
Teva Parenteral Medicines Inc
Taro Pharmaceutical Industries Ltd
Sandoz Inc
Ranbaxy Laboratories Ltd
Mylan Pharmaceuticals Inc
Lek Pharmaceuticals D D
Krka Dd Novo Mesto
Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa
Hospira Inc
Hikma Farmaceutica (Portugal) Sa
Biovail Laboratories International Srl
Bedford Laboratories Div Ben Venue Laboratories Inc
Apothecon Inc Div Bristol Myers Squibb
Apotex Inc
Enalapril Segment by Type
10mg
2.5mg
20mg
5mg
Enalapril Segment by Application
Hospital
Drugs Store
Enalapril Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Enalapril market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Enalapril and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Enalapril.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Enalapril market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Enalapril manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Enalapril in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Enalapril in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 10mg
- 2.5mg
- 20mg
- 5mg
Applications
- Hospital
- Drugs Store
Companies covered
- Wockhardt Americas Inc
- Watson Laboratories Inc
- Teva Pharmaceuticals Usa Inc
- Teva Parenteral Medicines Inc
- Taro Pharmaceutical Industries Ltd
- Sandoz Inc
- Ranbaxy Laboratories Ltd
- Mylan Pharmaceuticals Inc
- Lek Pharmaceuticals D D
- Krka Dd Novo Mesto
- Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa
- Hospira Inc
- Hikma Farmaceutica (Portugal) Sa
- Biovail Laboratories International Srl
- Bedford Laboratories Div Ben Venue Laboratories Inc
- Apothecon Inc Div Bristol Myers Squibb
- Apotex Inc
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Enalapril Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Enalapril Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Enalapril Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Enalapril Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Enalapril Market Dynamics
- 2.1 Enalapril Industry Trends
- 2.2 Enalapril Industry Drivers
- 2.3 Enalapril Industry Opportunities and Challenges
- 2.4 Enalapril Industry Restraints
3 Enalapril Market by Manufacturers
- 3.1 Global Enalapril Revenue by Manufacturers (2021-2026)
- 3.2 Global Enalapril Sales by Manufacturers (2021-2026)
- 3.3 Global Enalapril Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Enalapril Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Enalapril Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Enalapril Manufacturers, Product Type & Application
- 3.7 Global Enalapril Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Enalapril Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Enalapril Players Market Share by Revenue in 2025
- 3.8.3 2025 Enalapril Tier 1, Tier 2, and Tier 3
4 Enalapril Market by Type
- 4.1 Enalapril Type Introduction
- 4.1.1 10mg
- 4.1.2 2.5mg
- 4.1.3 20mg
- 4.1.4 5mg
- 4.2 Global Enalapril Sales by Type
- 4.2.1 Global Enalapril Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Enalapril Sales by Type (2021-2032)
- 4.2.3 Global Enalapril Sales Market Share by Type (2021-2032)
- 4.3 Global Enalapril Revenue by Type
- 4.3.1 Global Enalapril Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Enalapril Revenue by Type (2021-2032)
- 4.3.3 Global Enalapril Revenue Market Share by Type (2021-2032)
5 Enalapril Market by Application
- 5.1 Enalapril Application Introduction
- 5.1.1 Hospital
- 5.1.2 Drugs Store
- 5.2 Global Enalapril Sales by Application
- 5.2.1 Global Enalapril Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Enalapril Sales by Application (2021-2032)
- 5.2.3 Global Enalapril Sales Market Share by Application (2021-2032)
- 5.3 Global Enalapril Revenue by Application
- 5.3.1 Global Enalapril Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Enalapril Revenue by Application (2021-2032)
- 5.3.3 Global Enalapril Revenue Market Share by Application (2021-2032)
6 Global Enalapril Sales by Region
- 6.1 Global Enalapril Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Enalapril Sales by Region (2021-2032)
- 6.2.1 Global Enalapril Sales by Region (2021-2026)
- 6.2.2 Global Enalapril Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Enalapril Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Enalapril Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Enalapril Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Enalapril Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Enalapril Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Enalapril Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Enalapril Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Enalapril Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Enalapril Revenue by Region
- 7.1 Global Enalapril Revenue by Region
- 7.1.1 Global Enalapril Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Enalapril Revenue by Region (2021-2026)
- 7.1.3 Global Enalapril Revenue by Region (2027-2032)
- 7.1.4 Global Enalapril Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Enalapril Revenue (2021-2032)
- 7.2.2 North America Enalapril Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Enalapril Revenue (2021-2032)
- 7.3.2 Europe Enalapril Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Enalapril Revenue (2021-2032)
- 7.4.2 Asia-Pacific Enalapril Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Enalapril Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Enalapril Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Wockhardt Americas Inc
- 8.1.1 Wockhardt Americas Inc Company Information
- 8.1.2 Wockhardt Americas Inc Business Overview
- 8.1.3 Wockhardt Americas Inc Enalapril Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Wockhardt Americas Inc Enalapril Product Portfolio
- 8.1.5 Wockhardt Americas Inc Recent Developments
- 8.2 Watson Laboratories Inc
- 8.2.1 Watson Laboratories Inc Company Information
- 8.2.2 Watson Laboratories Inc Business Overview
- 8.2.3 Watson Laboratories Inc Enalapril Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Watson Laboratories Inc Enalapril Product Portfolio
- 8.2.5 Watson Laboratories Inc Recent Developments
- 8.3 Teva Pharmaceuticals Usa Inc
- 8.3.1 Teva Pharmaceuticals Usa Inc Company Information
- 8.3.2 Teva Pharmaceuticals Usa Inc Business Overview
- 8.3.3 Teva Pharmaceuticals Usa Inc Enalapril Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Teva Pharmaceuticals Usa Inc Enalapril Product Portfolio
- 8.3.5 Teva Pharmaceuticals Usa Inc Recent Developments
- 8.4 Teva Parenteral Medicines Inc
- 8.4.1 Teva Parenteral Medicines Inc Company Information
- 8.4.2 Teva Parenteral Medicines Inc Business Overview
- 8.4.3 Teva Parenteral Medicines Inc Enalapril Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Teva Parenteral Medicines Inc Enalapril Product Portfolio
- 8.4.5 Teva Parenteral Medicines Inc Recent Developments
- 8.5 Taro Pharmaceutical Industries Ltd
- 8.5.1 Taro Pharmaceutical Industries Ltd Company Information
- 8.5.2 Taro Pharmaceutical Industries Ltd Business Overview
- 8.5.3 Taro Pharmaceutical Industries Ltd Enalapril Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Taro Pharmaceutical Industries Ltd Enalapril Product Portfolio
- 8.5.5 Taro Pharmaceutical Industries Ltd Recent Developments
- 8.6 Sandoz Inc
- 8.6.1 Sandoz Inc Company Information
- 8.6.2 Sandoz Inc Business Overview
- 8.6.3 Sandoz Inc Enalapril Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Sandoz Inc Enalapril Product Portfolio
- 8.6.5 Sandoz Inc Recent Developments
- 8.7 Ranbaxy Laboratories Ltd
- 8.7.1 Ranbaxy Laboratories Ltd Company Information
- 8.7.2 Ranbaxy Laboratories Ltd Business Overview
- 8.7.3 Ranbaxy Laboratories Ltd Enalapril Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Ranbaxy Laboratories Ltd Enalapril Product Portfolio
- 8.7.5 Ranbaxy Laboratories Ltd Recent Developments
- 8.8 Mylan Pharmaceuticals Inc
- 8.8.1 Mylan Pharmaceuticals Inc Company Information
- 8.8.2 Mylan Pharmaceuticals Inc Business Overview
- 8.8.3 Mylan Pharmaceuticals Inc Enalapril Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Mylan Pharmaceuticals Inc Enalapril Product Portfolio
- 8.8.5 Mylan Pharmaceuticals Inc Recent Developments
- 8.9 Lek Pharmaceuticals D D
- 8.9.1 Lek Pharmaceuticals D D Company Information
- 8.9.2 Lek Pharmaceuticals D D Business Overview
- 8.9.3 Lek Pharmaceuticals D D Enalapril Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Lek Pharmaceuticals D D Enalapril Product Portfolio
- 8.9.5 Lek Pharmaceuticals D D Recent Developments
- 8.10 Krka Dd Novo Mesto
- 8.10.1 Krka Dd Novo Mesto Company Information
- 8.10.2 Krka Dd Novo Mesto Business Overview
- 8.10.3 Krka Dd Novo Mesto Enalapril Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Krka Dd Novo Mesto Enalapril Product Portfolio
- 8.10.5 Krka Dd Novo Mesto Recent Developments
- 8.11 Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa
- 8.11.1 Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa Company Information
- 8.11.2 Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa Business Overview
- 8.11.3 Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa Enalapril Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa Enalapril Product Portfolio
- 8.11.5 Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa Recent Developments
- 8.12 Hospira Inc
- 8.12.1 Hospira Inc Company Information
- 8.12.2 Hospira Inc Business Overview
- 8.12.3 Hospira Inc Enalapril Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Hospira Inc Enalapril Product Portfolio
- 8.12.5 Hospira Inc Recent Developments
- 8.13 Hikma Farmaceutica (Portugal) Sa
- 8.13.1 Hikma Farmaceutica (Portugal) Sa Company Information
- 8.13.2 Hikma Farmaceutica (Portugal) Sa Business Overview
- 8.13.3 Hikma Farmaceutica (Portugal) Sa Enalapril Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Hikma Farmaceutica (Portugal) Sa Enalapril Product Portfolio
- 8.13.5 Hikma Farmaceutica (Portugal) Sa Recent Developments
- 8.14 Biovail Laboratories International Srl
- 8.14.1 Biovail Laboratories International Srl Company Information
- 8.14.2 Biovail Laboratories International Srl Business Overview
- 8.14.3 Biovail Laboratories International Srl Enalapril Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Biovail Laboratories International Srl Enalapril Product Portfolio
- 8.14.5 Biovail Laboratories International Srl Recent Developments
- 8.15 Bedford Laboratories Div Ben Venue Laboratories Inc
- 8.15.1 Bedford Laboratories Div Ben Venue Laboratories Inc Company Information
- 8.15.2 Bedford Laboratories Div Ben Venue Laboratories Inc Business Overview
- 8.15.3 Bedford Laboratories Div Ben Venue Laboratories Inc Enalapril Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 Bedford Laboratories Div Ben Venue Laboratories Inc Enalapril Product Portfolio
- 8.15.5 Bedford Laboratories Div Ben Venue Laboratories Inc Recent Developments
- 8.16 Apothecon Inc Div Bristol Myers Squibb
- 8.16.1 Apothecon Inc Div Bristol Myers Squibb Company Information
- 8.16.2 Apothecon Inc Div Bristol Myers Squibb Business Overview
- 8.16.3 Apothecon Inc Div Bristol Myers Squibb Enalapril Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.16.4 Apothecon Inc Div Bristol Myers Squibb Enalapril Product Portfolio
- 8.16.5 Apothecon Inc Div Bristol Myers Squibb Recent Developments
- 8.17 Apotex Inc
- 8.17.1 Apotex Inc Company Information
- 8.17.2 Apotex Inc Business Overview
- 8.17.3 Apotex Inc Enalapril Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.17.4 Apotex Inc Enalapril Product Portfolio
- 8.17.5 Apotex Inc Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Enalapril Value Chain Analysis
- 9.1.1 Enalapril Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Enalapril Production Mode & Process
- 9.2 Enalapril Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Enalapril Distributors
- 9.2.3 Enalapril Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst